Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Phenelzine

Related Products

Hot Products

Basic Information Post buying leads Suppliers
Name

Phenelzine

EINECS 200-117-9
CAS No. 51-71-8 Density 1.01 g/cm3
PSA 38.05000 LogP 1.78360
Solubility N/A Melting Point 25°C
Formula C8H12 N2 Boiling Point 281.4 °C at 760 mmHg
Molecular Weight 136.197 Flash Point 143.7 °C
Transport Information N/A Appearance N/A
Safety Poison by ingestion, intraperitoneal, and subcutaneous routes. Human systemic effects by ingestion: ataxia, somnolence. An experimental teratogen. Experimental reproductive effects. Mutation data reported. Used as an antidepressant. When heated to decomposition it emits toxic fumes of NOx. Risk Codes N/A
Molecular Structure Molecular Structure of 51-71-8 (Phenelzine) Hazard Symbols IrritantXi
Synonyms

Hydrazine,phenethyl- (6CI,8CI); 1-(2-Phenethyl)hydrazine; 1-(2-Phenylethyl)hydrazine;1-Hydrazino-2-phenylethane; 2-Phenylethylhydrazine; Phenalzine; Phenelzine;Phenethylhydrazine; Phenylethylhydrazine; W 1544; b-Phenylethylhydrazine

 

Phenelzine Chemical Properties

Chemistry informtion about 2-Phenylethylhydrazine (CAS NO.51-71-8) is:
IUPAC Name: Phenethylhydrazine
Synonyms: Asinex-Reag Bas 07650440 ; Beta-Phenylethylhydrazine ; 2-Phenelzine ; (2-Phenyl-Ethyl)-Hydrazine ; Phenethyl Hydrazine ; Phenelzine ; (2-Phenylethyl)-Hydrazin ; 1-(2-Phenylethyl)Hydrazine
MF: C8H12N2
MW: 136.19
EINECS: 200-117-9
Density: 1.01 g/cm3
Flash Point: 143.7 °C
Boiling Point: 281.4 °C at 760 mmHg
Vapour Pressure: 0.00358 mmHg at 25°C 
Enthalpy of Vaporization: 52.02 kJ/mol
Following is the molecular structure of 2-Phenylethylhydrazine (CAS NO.51-71-8) is:

Phenelzine Uses

 2-Phenylethylhydrazine (CAS NO.51-71-8) is used primarily in the treatment of major depressive disorder (MDD). Patients with depressive symptomology characterized as "atypical", "nonendogenous", and/or "neurotic", have been reported to respond particularly well to phenelzine. The medication has also been found to be useful in patients who do not respond favorably to first and second-line treatments for depression, or are said to be "treatment-resistant". In addition to being a recognized treatment for major depressive disorder, it has been found in studies to be effective in treating dysthymia, bipolar depression (BD), panic disorder (PD), social anxiety disorder (SAD), bulimia, and post-traumatic stress disorder (PTSD).

Phenelzine Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
child TDLo oral 7500ug/kg (7.5mg/kg) behavioral: ataxia behavioral: somnolence (general depressed activity) American Journal of Diseases of Children. Vol. 130, Pg. 507, 1976.
mouse LD50 intraperitoneal 135mg/kg (135mg/kg)   Farmakologiya i Toksikologiya Vol. 32, Pg. 526, 1969.
mouse LD50 oral 130mg/kg (130mg/kg)   Biochemical Pharmacology. Vol. 17, Pg. 369, 1968.
mouse LD50 subcutaneous 122mg/kg (122mg/kg)   Farmakologiya i Toksikologiya Vol. 37, Pg. 651, 1974.
women LDLo oral 30mg/kg (30mg/kg) lungs, thorax, or respiration: acute pulmonary edema liver: fatty liver degeration Journal of Analytical Toxicology. Vol. 19, Pg. 265, 1995.
women TDLo oral 39600ug/kg/44 (39.6mg/kg) behavioral: "hallucinations, distorted perceptions" behavioral: toxic psychosis behavioral: muscle contraction or spasticity) Journal of Clinical Psychiatry. Vol. 48, Pg. 340, 1987.

Phenelzine Safety Profile

Poison by ingestion, intraperitoneal, and subcutaneous routes. Human systemic effects by ingestion: ataxia, somnolence. An experimental teratogen. Experimental reproductive effects. Mutation data reported. Used as an antidepressant. When heated to decomposition it emits toxic fumes of NOx.
Hazard Codes:
IrritantXi

Phenelzine Specification

 2-Phenylethylhydrazine (CAS NO.51-71-8) is an irreversible and nonselective and monoamine oxidase inhibitor (MAOI) of the hydrazine chemical class which is used as an antidepressant and anxiolytic. Along with tranylcypromine and isocarboxazid, phenelzine is one of the few nonselective MAOIs still in widespread clinical use. 2-Phenylethylhydrazine and the other MAOIs are typically considered to be significantly more effective against clinical depression in comparison to more mainstream antidepressants like the selective serotonin reuptake inhibitors (SSRIs), but are usually reserved only as a last resort due to their prominent side effects and potentially hazardous food and drug interactions. Notably, phenelzine has shown unique efficacy in treating anxiety disorders, likely due to its actions on GABA concentrations.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 51-71-8